The effectiveness of neurodynamic techniques in diabetic peripheral neuropathy.

Not Applicable

Recruiting

Conditions: Diabetic peripheral neuropathy.
Polyneuropathy in diseases classified elsewhere
G63.2

Registration Number: IRCT20220401054379N1

Lead Sponsor: Iran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

1.Adults (18-70 years) diagnosed with T2DM by an expert endocrinologist based on their most recent test (within the past 3 months).
2. Patients diagnosed with diabetic peripheral neuropathy based on electrodiagnostic study that was taken by an expert physiatrist.
3.Included patients must have at least 90° hip flexion, full knee extension, and 0° dorsiflexion to 30° plantarflexion

Exclusion Criteria

1. Lasting low back pain, neck pain, and sciatalgia (at least for 3 days) in the last 6 months
2. History of chemotherapy or spinal surgery in the last year
3. History of peripheral nerves' injury or surgery
4. Alcohol or chemical addiction
5. Pregnancy
6. Syphilis, Guillain barre syndrome, rheumatoid arthritis
7. Infection or open wound in the lower limbs
8. Amputation proximal to the metatarsophalangeal joint
9. Complex regional pain syndrome
10. Tarsal tunnel syndrome
11. Severe diabetic peripheral neuropathy (3012. Personal reluctance to paticipate in the present study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Michigan Diabetic Neuropathy Score(MDNS). Timepoint: MDNS as the primary outcome of the present study will be evaluated before the study and at the last session. Method of measurement: The Michigan Diabetic Neuropathy Score(MDNS).

Secondary Outcome Measures

Name	Time	Method
Tibial nerve conduction velocity. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan).;Tibial nerve's distal latency. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan) .;Amplitude of motor nerve action potential. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan) .;Quality of life. Timepoint: Before the study and at the last session. Method of measurement: Persian localized version of Neuro QoL questionnaire.;Straight leg raising range of motion. Timepoint: Before the study and at the last session. Method of measurement: Manual goniometer.;F-wave latency. Timepoint: Before the study and at the last session. Method of measurement: Nerve condyution study unit (Neuropack®, s1 MEB-9400, Nihon Kohden, Japan) .